MTHFR: what the gene variant actually means

MTHFR may be the most tested, most blamed and most oversold gene variant on the internet — and the mainstream position on it is worth hearing precisely because it is so much less exciting.

What MTHFR actually is

MTHFR is a gene for an enzyme in the folate cycle — the machinery that processes folate and, along the way, recycles homocysteine. Two common variants slightly reduce the enzyme's efficiency. The operative word is common: depending on ancestry, a third or more of people carry at least one copy of the better-known variant, and around one in ten carry two.

That prevalence is itself the argument for calm. A variant carried by a third of humanity is a normal part of human variation — not a mutation, not a diagnosis, and not a plausible explanation for why one individual feels unwell.

What the variants measurably do

Reduced enzyme efficiency can modestly raise homocysteine — mainly when folate intake is low, because adequate folate largely compensates. In Australia and New Zealand, where bread-making flour is fortified with folic acid, population folate status is good, which shrinks the variant's practical footprint further.

This points to the sensible test when there is a genuine clinical question: measure the thing itself. Homocysteine shows whether the pathway is actually struggling; the genotype only shows whether it theoretically might. Australian pathology guidance has landed exactly there — routine MTHFR genotyping is not recommended, because the result rarely changes anything a direct measurement wouldn't handle better.

What the internet added

Online, MTHFR has become an explanation for fatigue, anxiety, and a catalogue of chronic complaints — with a supplement protocol attached, usually featuring methylated vitamins at a premium. The claims outrun the evidence by a wide margin. For pregnancy specifically: standard folic acid guidance applies to women with these variants like everyone else, and anyone told otherwise deserves a second opinion from their doctor rather than a forum.

None of this dismisses the person who feels unwell. It redirects the search — because pinning persistent symptoms on a near-universal variant mostly ends the investigation that should have continued.

What an MTHFR result won't tell you

• Why you're tired. A variant this common cannot explain individual symptoms — the workup for those runs through a GP.
• That you need special supplements. Fortification and ordinary folate intake cover the variant's effect for almost everyone.
• Your homocysteine. If the pathway's performance matters clinically, measure it — the level, not the genotype, is the finding.
• That anything is wrong. Most carriers live entire healthy lives never knowing; knowing changes nothing about that.

The bottom line

MTHFR variants are common, their measurable effect is small and largely neutralised by adequate folate, and the direct test — homocysteine — answers the only question the genotype raises. The gene deserves its footnote; it has been given a franchise.